Citation: | CHEN Leilin, SONG Min, ZHANG Ge, WANG Lei, HANG Taijun. Identification of related substances in ambrisentan by LC-MS/MS[J]. Journal of China Pharmaceutical University, 2016, 47(1): 58-65. DOI: 10.11665/j.issn.1000-5048.20160108 |
[1] |
Hrometz SL,Shields KM.Role of ambrisentan in the management of pulmonary hypertension[J].Ann Pharmacother,2008,42(11):1653-1659.
|
[2] |
Cheng JW.Ambrisentan for the management of pulmonary arterial hypertension[J].Clin Ther,2008,30(5):825-833.
|
[3] |
Guo W.Potential drug for pulmonary arterial hypertension will rise[J].Shanghai Med Pharm J(上海医药),2007,28(4):160-161.
|
[4] |
Jiang XP.To observe the development strategy of drug standards through Chinese Pharmacopoeia 2010 Edition[J].Chin Pharm J(中国药学杂志),2010,45(17):1281-1283.
|
1. |
曹广生,徐巧,郑新勇,何宽,李剑,杨继伟,俞晓峰. 超高效液相色谱-三重四极杆串联质谱法检测毛发中依托咪酯及其代谢物和美托咪酯. 分析试验室. 2025(04): 592-596 .
![]() | |
2. |
郑新勇,曹广生,王辰雪,刘宸,李旭阳,宋昕. 超高效液相色谱-串联质谱法测定毛发中7种新型苯二氮■类策划药物的含量. 理化检验-化学分册. 2023(12): 1425-1430 .
![]() |